Scarica l'app Stockscreener
43.36
3.15%
-1.41
Dopo l'orario di chiusura:
43.61
0.25
+0.58%
Precedente Chiudi:
$44.77
Aprire:
$45
Volume 24 ore:
74,411
Relative Volume:
1.63
Capitalizzazione di mercato:
$305.43M
Reddito:
-
Utile/perdita netta:
$-4.98M
Rapporto P/E:
-32.91
EPS:
-1.3177
Flusso di cassa netto:
$-3.85M
1 W Prestazione:
+0.79%
1M Prestazione:
+22.30%
6M Prestazione:
+27.94%
1 anno Prestazione:
+3,483%
Intervallo 1D:
$42.55
$45.00
Intervallo di 1 settimana:
$41.00
$45.00
Portata 52W:
$0.94
$79.02
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Nome
Bright Minds Biosciences Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta DRUG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DRUG
Bright Minds Biosciences Inc
|
43.36 | 317.18M | 0 | -4.98M | -3.85M | -1.3177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-13 | Iniziato | TD Cowen | Buy |
| 2025-05-07 | Iniziato | Chardan Capital Markets | Buy |
| 2025-01-23 | Iniziato | Piper Sandler | Overweight |
| 2025-01-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-01-10 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-26 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Bright Minds Biosciences Inc Borsa (DRUG) Ultime notizie
Why Bright Minds Biosciences Inc. is moving todayJuly 2025 Trade Ideas & Verified Entry Point Detection - Newser
Will Bright Minds Biosciences Inc. benefit from macro trendsTrade Analysis Summary & Daily Oversold Stock Bounce Ideas - Newser
Visual analytics tools that track Bright Minds Biosciences Inc. performanceStock Surge & Free High Accuracy Swing Entry Alerts - Newser
What momentum shifts mean for Bright Minds Biosciences Inc.2025 Market Sentiment & Reliable Intraday Trade Alerts - Newser
Is Bright Minds Biosciences Inc. stock bottoming outMarket Performance Report & Daily Entry Point Alerts - Newser
Analyzing Bright Minds Biosciences Inc. with risk reward ratio chartsJuly 2025 Weekly Recap & Daily Profit Focused Stock Screening - Newser
Applying Wyckoff theory to Bright Minds Biosciences Inc. stock2025 Earnings Impact & Weekly Top Gainers Trade List - Newser
How to read the order book for Bright Minds Biosciences Inc.2025 Risk Factors & Expert Approved Momentum Ideas - Newser
RKTN(rocket token space) Price PredictionMarket Activity Report & Stepwise Entry and Exit Trade Signals - Newser
Forecasting Bright Minds Biosciences Inc. price range with options dataNew Guidance & Smart Money Movement Alerts - Newser
Volume spikes in Bright Minds Biosciences Inc. stock – what they meanJuly 2025 Movers & Safe Capital Investment Plans - Newser
Using economic indicators to assess Bright Minds Biosciences Inc. potentialJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - Newser
Earnings visualization tools for Bright Minds Biosciences Inc.Market Weekly Review & Daily Stock Trend Watchlist - Newser
Financial Comparison: Bright Minds Biosciences (NASDAQ:DRUG) & Bolt Biotherapeutics (NASDAQ:BOLT) - Defense World
CNS Drug Developer Bright Minds Biosciences Lines Up Four Major Healthcare Conference Presentations - Stock Titan
Sentiment analysis tools applied to Bright Minds Biosciences Inc.Weekly Trend Recap & Comprehensive Market Scan Insights - Newser
How to track smart money flows in Bright Minds Biosciences Inc.July 2025 Decliners & Smart Money Movement Alerts - Newser
Bright Minds Biosciences Inc.’s Beta Climbs After Market VolatilityGap Down & Safe Entry Trade Reports - beatles.ru
FY2025 EPS Estimates for DRUG Raised by Cantor Fitzgerald - Defense World
HC Wainwright Has Positive Outlook of DRUG FY2025 Earnings - Defense World
Should I set a stop loss on Bright Minds Biosciences Inc.July 2025 Update & Free Risk Controlled Daily Trade Plans - theviewers.co.kr
Smart tools for monitoring Bright Minds Biosciences Inc.’s price actionPortfolio Value Summary & Low Risk High Reward Trade Ideas - Newser
Is There Enough Volume to Lift Bright Minds Biosciences Inc.Market Activity Recap & Stepwise Trade Signal Implementation - mustnews.co.kr
Bright Minds Biosciences: Bright Prospects for Epilepsy Treatment with BMB-101 and Strong Financial Position - AInvest
HC Wainwright & Co. Reiterates "Buy" Rating for Bright Minds Biosciences with $85 Price Target - AInvest
Bright Minds Biosciences Reports Q3 2025 Financial Results - MSN
Bright Minds Biosciences stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Nigeria
Bright Minds Biosciences stock maintains Buy rating at H.C. Wainwright - Investing.com
Bright Minds Biosciences (NASDAQ:DRUG) Given Buy Rating at HC Wainwright - Defense World
New Product Launches: Will They Boost Bright Minds Biosciences Inc. Stock in 2025Market Rally & Advanced Technical Signal Analysis - Newser
What makes Bright Minds Biosciences Inc. stock price move sharplyStop Loss & Stepwise Swing Trade Plans - Newser
Using flow based indicators on Contineum Therapeutics Inc.Weekly Stock Recap & Weekly Stock Performance Updates - Newser
Bright Minds Biosciences Inc. stock outlook for YEAR2025 Bull vs Bear & AI Forecasted Stock Moves - Newser
Brokerages Set Bright Minds Biosciences Inc. (NASDAQ:DRUG) Price Target at $83.25 - Defense World
Bright Minds Biosciences Inc. Stock Recovery Path — Analyst BreakdownMarket Rally & Reliable Price Breakout Alerts - beatles.ru
Bright Minds rally ends as psychedelic stocks extend volatility - MSN
Bright Minds Biosciences Inc Azioni (DRUG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):